WWL123 is a potent and selective ABHD6 inhibitor (IC50 = 430 nM) that crosses the blood-brain barrier and inhibits ABHD6 in the brain parenchyma; it exerts anticonvulsant effects by blocking ABHD6 in pentylenetetrazole (PTZ)-induced epileptiform seizures and spontaneous seizures in R6/2 mice.